Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1996;94:2968-2974

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goette, A.
Right arrow Articles by Langberg, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goette, A.
Right arrow Articles by Langberg, J. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Atrial Fibrillation
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*VERAPAMIL HYDROCHLORIDE

(Circulation. 1996;94:2968-2974.)
© 1996 American Heart Association, Inc.


Articles

Electrical Remodeling in Atrial Fibrillation

Time Course and Mechanisms

Andreas Goette, MD; Clegg Honeycutt, BS; Jonathan J. Langberg, MD

the Carlyle Fraser Heart Center and the Division of Cardiology, Emory University Hospital, Atlanta, Ga.

Background Atrial fibrillation is self-perpetuating, suggesting that the tachyarrhythmia causes electrophysiological changes that contribute to the progressive nature of the disease. In animal models, pacing-induced rapid atrial rates result in sustained atrial fibrillation. This is mediated by shortening of refractory periods termed electrical remodeling. The purpose of the present study was to characterize the time course of electrical remodeling and to define mechanisms of the phenomenon.

Methods and Results Closed-chest dogs were anesthetized, pretreated with atropine and propranolol, and subjected to 7 hours of atrial pacing at 800 bpm. The effective and absolute refractory periods (ARP and ERP) were measured during and after rapid pacing, and transvenous endocardial biopsy specimens were examined using electron microscopy. Despite autonomic blockade and the absence of change in right atrial pressure, persistent atrial tachycardia caused ARP and ERP to fall by >10%. Electrical remodeling developed quickly, with more than half of the phenomenon occurring during the first 30 minutes of high-rate pacing. Pretreatment with glibenclamide in doses sufficient to block the ATP-sensitive potassium current had no effect. Atrial electrical remodeling was blocked by verapamil and accentuated by hypercalcemia. Biopsy specimens from controls subjected to rapid pacing showed mitochondrial swelling consistent with calcium overload. Biopsies from verapamil-treated animals were normal.

Conclusions Atrial electrical remodeling develops quickly, is progressive, and may be persistent. Shifts in autonomic tone, atrial stretch, or depletion of high-energy phosphates do not contribute significantly to the phenomenon. Results of the study suggest that atrial electrical remodeling is mediated by rate-induced intracellular calcium overload.


Key Words: atrium • fibrillation • calcium • electrophysiology




This article has been cited by other articles:


Home page
EuropaceHome page
S. K. Kim, H.-N. Pak, J. H. Park, K. J. Ko, J. S. Lee, J. I. Choi, D. H. Choi, and Y.-H. Kim
Clinical and serological predictors for the recurrence of atrial fibrillation after electrical cardioversion
Europace, December 1, 2009; 11(12): 1632 - 1638.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
K. Nishida, G. Michael, D. Dobrev, and S. Nattel
Animal models for atrial fibrillation: clinical insights and scientific opportunities
Europace, October 29, 2009; (2009) eup328v1.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Anter and D. J. Callans
Pharmacological and Electrical Conversion of Atrial Fibrillation to Sinus Rhythm Is Worth the Effort
Circulation, October 6, 2009; 120(14): 1436 - 1443.
[Full Text] [PDF]


Home page
EuropaceHome page
F. Hegbom, A. Tveit, I. Grundvold, H. Arnesen, and P. Smith
Effects of angiotensin receptor blockade on serial P-wave signal-averaged electrocardiograms after electrical cardioversion of persistent atrial fibrillation
Europace, October 1, 2009; 11(10): 1301 - 1307.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Matsuo, N. Lellouche, M. Wright, M. Bevilacqua, S. Knecht, I. Nault, K.-T. Lim, L. Arantes, M. D. O'Neill, P. G. Platonov, et al.
Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation.
J. Am. Coll. Cardiol., August 25, 2009; 54(9): 788 - 795.
[Abstract] [Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
J. H. Rennison and D. R. Van Wagoner
Impact of Dietary Fatty Acids on Cardiac Arrhythmogenesis
Circ Arrhythm Electrophysiol, August 1, 2009; 2(4): 460 - 469.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. K. Stiles, B. John, C. X. Wong, P. Kuklik, A. G. Brooks, D. H. Lau, H. Dimitri, K. C. Roberts-Thomson, L. Wilson, P. De Sciscio, et al.
Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate characterizing the "second factor".
J. Am. Coll. Cardiol., April 7, 2009; 53(14): 1182 - 1191.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
X. Y. Qi, Y.-H. Yeh, L. Xiao, B. Burstein, A. Maguy, D. Chartier, L. R. Villeneuve, B. J.J.M. Brundel, D. Dobrev, and S. Nattel
Cellular Signaling Underlying Atrial Tachycardia Remodeling of L-type Calcium Current
Circ. Res., October 10, 2008; 103(8): 845 - 854.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Bukowska, U. Lendeckel, A. Krohn, G. Keilhoff, S. t. Have, K. H. Neumann, and A. Goette
Atrial fibrillation down-regulates renal neutral endopeptidase expression and induces profibrotic pathways in the kidney
Europace, October 1, 2008; 10(10): 1212 - 1217.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
R. Laszlo, C. Eick, N. Rueb, S. Weretka, H.-J. Weig, J. Schreieck, and R. F Bosch
Inhibition of the renin-angiotensin system: effects on tachycardia-induced early electrical remodelling in rabbit atrium
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2008; 9(3): 125 - 132.
[Abstract] [PDF]


Home page
Eur Heart JHome page
C. W. Israel
Effect of statins in 'upstream therapy' of atrial fibrillation: better reliability with implantable cardiac monitors
Eur. Heart J., August 1, 2008; 29(15): 1798 - 1799.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Rostock, D. Steven, B. Lutomsky, H. Servatius, I. Drewitz, H. Klemm, K. Mullerleile, R. Ventura, T. Meinertz, and S. Willems
Atrial fibrillation begets atrial fibrillation in the pulmonary veins on the impact of atrial fibrillation on the electrophysiological properties of the pulmonary veins in humans.
J. Am. Coll. Cardiol., June 3, 2008; 51(22): 2153 - 2160.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
J. L. Serra and M. Bendersky
Review: Atrial fibrillation and renin-angiotensin system
Therapeutic Advances in Cardiovascular Disease, June 1, 2008; 2(3): 215 - 223.
[Abstract] [PDF]


Home page
Eur Heart JHome page
S. Dinanian, C. Boixel, C. Juin, J.-S. Hulot, A. Coulombe, C. Rucker-Martin, N. Bonnet, B. Le Grand, M. Slama, J.-J. Mercadier, et al.
Downregulation of the calcium current in human right atrial myocytes from patients in sinus rhythm but with a high risk of atrial fibrillation
Eur. Heart J., May 1, 2008; 29(9): 1190 - 1197.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. Bukowska, L. Schild, G. Keilhoff, D. Hirte, M. Neumann, A. Gardemann, K. H. Neumann, F.-W. Rohl, C. Huth, A. Goette, et al.
Mitochondrial Dysfunction and Redox Signaling in Atrial Tachyarrhythmia
Experimental Biology and Medicine, May 1, 2008; 233(5): 558 - 574.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. Moreira, R. Manusama, C. Timmermans, B. Ghaye, S. Philippens, H. J.J. Wellens, and L.-M. Rodriguez
Long-Term Follow-Up After Cryothermic Ostial Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation
J. Am. Coll. Cardiol., February 26, 2008; 51(8): 850 - 855.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Goette, A. Bukowska, U. Lendeckel, M. Erxleben, M. Hammwohner, D. Strugala, J. Pfeiffenberger, F.-W. Rohl, C. Huth, M. P.A. Ebert, et al.
Angiotensin II Receptor Blockade Reduces Tachycardia-Induced Atrial Adhesion Molecule Expression
Circulation, February 12, 2008; 117(6): 732 - 742.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Mayr, S. Yusuf, G. Weir, Y.-L. Chung, U. Mayr, X. Yin, C. Ladroue, B. Madhu, N. Roberts, A. De Souza, et al.
Combined metabolomic and proteomic analysis of human atrial fibrillation.
J. Am. Coll. Cardiol., February 5, 2008; 51(5): 585 - 594.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Casaclang-Verzosa, B. J. Gersh, and T. S.M. Tsang
Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.
J. Am. Coll. Cardiol., January 1, 2008; 51(1): 1 - 11.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Moreira, C. Timmermans, H. J.J. Wellens, Y. Mizusawa, S. Philippens, D. Perez, and L.-M. Rodriguez
Can Common-Type Atrial Flutter Be a Sign of an Arrhythmogenic Substrate in Paroxysmal Atrial Fibrillation?: Clinical and Ablative Consequences in Patients With Coexistent Paroxysmal Atrial Fibrillation/Atrial Flutter
Circulation, December 11, 2007; 116(24): 2786 - 2792.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
S. Niwano, H. Fukaya, T. Sasaki, Y. Hatakeyama, A. Fujiki, and T. Izumi
Effect of oral L-type calcium channel blocker on repetitive paroxysmal atrial fibrillation: spectral analysis of fibrillation waves in the Holter monitoring
Europace, December 1, 2007; 9(12): 1209 - 1215.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. K Nergardh, M. Rosenqvist, R. Nordlander, and M. Frick
Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study
Eur. Heart J., June 1, 2007; 28(11): 1351 - 1357.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
A. V. Mattioli, S. Bonatti, and G. Mattioli
Left Atrial Anatomy and Function After Conversion From Atrial Fibrillation in Hypertrophic Hearts
Angiology, January 1, 2007; 57(6): 717 - 723.
[Abstract] [PDF]


Home page
Eur Heart JHome page
F. Holmqvist, M. Stridh, J. E.P. Waktare, L. Sornmo, S. B. Olsson, and C. J. Meurling
Atrial fibrillatory rate and sinus rhythm maintenance in patients undergoing cardioversion of persistent atrial fibrillation
Eur. Heart J., September 2, 2006; 27(18): 2201 - 2207.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Y. Yin, D. Dalal, Z. Liu, J. Wu, D. Liu, X. Lan, Y. Dai, L. Su, Z. Ling, Q. She, et al.
Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation
Eur. Heart J., August 1, 2006; 27(15): 1841 - 1846.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Holmqvist, M. Stridh, J. E. P. Waktare, J. Brandt, L. Sornmo, A. Roijer, and C. J. Meurling
Rapid fluctuations in atrial fibrillatory electrophysiology detected during controlled respiration
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H754 - H760.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. P. Anyukhovsky, E. A. Sosunov, P. Chandra, T. S. Rosen, P. A. Boyden, P. Danilo Jr., and M. R. Rosen
Age-associated changes in electrophysiologic remodeling: a potential contributor to initiation of atrial fibrillation
Cardiovasc Res, May 1, 2005; 66(2): 353 - 363.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. A. Vest, X. H.T. Wehrens, S. R. Reiken, S. E. Lehnart, D. Dobrev, P. Chandra, P. Danilo, U. Ravens, M. R. Rosen, and A. R. Marks
Defective Cardiac Ryanodine Receptor Regulation During Atrial Fibrillation
Circulation, April 26, 2005; 111(16): 2025 - 2032.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
U Wetzel, A Boldt, J Lauschke, J Weigl, P Schirdewahn, A Dorszewski, N Doll, G Hindricks, S Dhein, and H Kottkamp
Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies
Heart, February 1, 2005; 91(2): 166 - 170.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Y. Xu, Z. Zhang, V. Timofeyev, D. Sharma, D. Xu, D. Tuteja, P. H. Dong, G. U. Ahmmed, Y. Ji, G. E Shull, et al.
The effects of intracellular Ca2+ on cardiac K+ channel expression and activity: novel insights from genetically altered mice
J. Physiol., February 1, 2005; 562(3): 745 - 758.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
C. Sticherling, S. Behrens, W. Kamke, A. Stahn, and M. Zabel
Comparison of acute and long-term effects of single-dose amiodarone and verapamil for the treatment of immediate recurrences of atrial fibrillation after transthoracic cardioversion
Europace, January 1, 2005; 7(6): 546 - 553.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Ueda, D. P. Zipes, and J. Wu
Functional and transmural modulation of M cell behavior in canine ventricular wall
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2569 - H2575.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Deroubaix, T. Folliguet, C. Rucker-Martin, S. Dinanian, C. Boixel, P. Validire, P. Daniel, A. Capderou, and S. N. Hatem
Moderate and chronic hemodynamic overload of sheep atria induces reversible cellular electrophysiologic abnormalities and atrial vulnerability
J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1918 - 1926.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Shiroshita-Takeshita, G. Schram, J. Lavoie, and S. Nattel
Effect of Simvastatin and Antioxidant Vitamins on Atrial Fibrillation Promotion by Atrial-Tachycardia Remodeling in Dogs
Circulation, October 19, 2004; 110(16): 2313 - 2319.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
R. Guinamard, A. Chatelier, M. Demion, D. Potreau, S. Patri, M. Rahmati, and P. Bois
Functional characterization of a Ca2+-activated non-selective cation channel in human atrial cardiomyocytes
J. Physiol., July 1, 2004; 558(1): 75 - 83.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C-J A Lindholm, O Fredholm, S-J Moller, N Edvardsson, T Kronvall, T Pettersson, V Firsovaite, A Roijer, C J Meurling, P G Platonov, et al.
Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil
Heart, May 1, 2004; 90(5): 534 - 538.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. Wasson, H. K. Reddy, and M. L. Dohrmann
Current Perspectives of Electrical Remodeling and Its Therapeutic Implications
Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 2004; 9(2): 129 - 144.
[Abstract] [PDF]


Home page
CirculationHome page
D. M. Todd, S. P. Fynn, A. P. Walden, W. J. Hobbs, S. Arya, and C. J. Garratt
Repetitive 4-Week Periods of Atrial Electrical Remodeling Promote Stability of Atrial Fibrillation: Time Course of a Second Factor Involved in the Self-Perpetuation of Atrial Fibrillation
Circulation, March 23, 2004; 109(11): 1434 - 1439.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Nakano, S. Niida, K. Dote, S. Takenaka, H. Hirao, F. Miura, M. Ishida, T. Shingu, T. Sueda, M. Yoshizumi, et al.
Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation
J. Am. Coll. Cardiol., March 3, 2004; 43(5): 818 - 825.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. M. Porthan, J. H. Melin, J. T. Kupila, K. K. K. Venho, and M. M. Partinen
Prevalence of Sleep Apnea Syndrome in Lone Atrial Fibrillation: A Case-Control Study
Chest, March 1, 2004; 125(3): 879 - 885.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
P. Spurrell, K. Kamalvand, M. Higson, and N. Sulke
Temporal changes in atrial refractoriness following DC cardioversion of persistent atrial fibrillation in man
Europace, January 1, 2004; 6(3): 229 - 235.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
T. Van Noord, R. G. Tieleman, H. A. Bosker, T. Kingma, D. J. Van Veldhuisen, H. J.G.M Crijns, and I. C. Van Gelder
Beta-blockers prevent subacute recurrences of persistent atrial fibrillation only in patients with hypertension
Europace, January 1, 2004; 6(4): 343 - 350.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K.-C. Ueng, T.-P. Tsai, W.-C. Yu, C.-F. Tsai, M.-C. Lin, K.-C. Chan, C.-Y. Chen, D.-J. Wu, C.-S. Lin, and S.-A. Chen
Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation: Results of a prospective and controlled study
Eur. Heart J., December 1, 2003; 24(23): 2090 - 2098.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
G.L. Botto, M. Luzi, and A. Sagone
Atrial fibrillation: the remodelling phenomenon
Eur. Heart J. Suppl., September 1, 2003; 5(suppl_H): H1 - H7.
[Abstract] [PDF]


Home page
Eur Heart JHome page
A. De Simone, M. De Pasquale, C. De Matteis, M. Canciello, M. Manzo, L. Sabino, F. Alfano, M. Di Mauro, A. Campana, G. De Fabrizio, et al.
VErapamil Plus Antiarrhythmic drugs Reduce Atrial Fibrillation recurrences after an electrical cardioversion (VEPARAF Study)
Eur. Heart J., August 1, 2003; 24(15): 1425 - 1429.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Kumagai, H. Nakashima, H. Urata, N. Gondo, K. Arakawa, and K. Saku
Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation
J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2197 - 2204.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
G. C. Gronefeld and S. H. Hohnloser
Heart Failure Complicated by Atrial Fibrillation: Mechanistic, Prognostic, and Therapeutic Implications
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 107 - 113.
[Abstract] [PDF]


Home page
CirculationHome page
J. G. Akar, T. H. Everett, R. Ho, J. Craft, D. E. Haines, A. P. Somlyo, and A. V. Somlyo
Intracellular Chloride Accumulation and Subcellular Elemental Distribution During Atrial Fibrillation
Circulation, April 8, 2003; 107(13): 1810 - 1815.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. F. Bosch, C. R. Scherer, N. Rub, S. Wohrl, K. Steinmeyer, H. Haase, A. E. Busch, L. Seipel, and V. Kuhlkamp
Molecular mechanisms of early electrical remodeling: transcriptional downregulation of ion channel subunits reduces ICa,L and Ito in rapid atrial pacing in rabbits
J. Am. Coll. Cardiol., March 5, 2003; 41(5): 858 - 869.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. A. Hassan, H. Oral, C. Scharf, A. Chugh, F. Pelosi, B. P. Knight, S. A. Strickberger, and F. Morady
Rate-dependent effect of verapamil on atrial refractoriness
J. Am. Coll. Cardiol., February 5, 2003; 41(3): 446 - 451.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. M. Narayan, F. Bode, P. L. Karasik, and M. R. Franz
Alternans of Atrial Action Potentials During Atrial Flutter as a Precursor to Atrial Fibrillation
Circulation, October 8, 2002; 106(15): 1968 - 1973.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
E. Bertaglia, D. D'Este, F. Zerbo, F. Zoppo, P. Delise, and P. Pascotto
Success of serial external electrical cardioversion of persistent atrial fibrillation in maintaining sinus rhythm. A randomized study
Eur. Heart J., October 1, 2002; 23(19): 1522 - 1528.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. van der Laarse
Hypothesis: troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure
Cardiovasc Res, October 1, 2002; 56(1): 8 - 14.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Miyata, D. P. Zipes, S. Hall, and M. Rubart
KB-R7943 Prevents Acute, Atrial Fibrillation-Induced Shortening of Atrial Refractoriness in Anesthetized Dogs
Circulation, September 10, 2002; 106(11): 1410 - 1419.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
C. Sticherling, M. Ozaydin, H. Tada, H. Oral, F. Pelosi, B. P. Knight, S. A. Strickberger, and F. Morady
Comparison of Verapamil and Ibutilide for the Suppression of Immediate Recurrences of Atrial Fibrillation after Transthoracic Cardioversion
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2002; 7(3): 155 - 160.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Goette, M. Arndt, C. Rocken, T. Staack, R. Bechtloff, D. Reinhold, C. Huth, S. Ansorge, H. U. Klein, and U. Lendeckel
Calpains and cytokines in fibrillating human atria
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H264 - H272.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. M. Cooper, M. S. Katcher, and M. V. Orlov
Implantable Devices for the Treatment of Atrial Fibrillation
N. Engl. J. Med., June 27, 2002; 346(26): 2062 - 2068.
[Full Text] [PDF]


Home page
CirculationHome page
K. Fan, K. L. Lee, W.-H. Chow, E. Chau, and C.-P. Lau
Internal Cardioversion of Chronic Atrial Fibrillation During Percutaneous Mitral Commissurotomy: Insight Into Reversal of Chronic Stretch-Induced Atrial Remodeling
Circulation, June 11, 2002; 105(23): 2746 - 2752.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Goette, U. Lendeckel, and H. U Klein
Signal transduction systems and atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 247 - 258.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. F Bosch and S. Nattel
Cellular electrophysiology of atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 259 - 269.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. J.J.M. Brundel, R. H. Henning, H. H. Kampinga, I. C. Van Gelder, and H. J.G.M. Crijns
Molecular mechanisms of remodeling in human atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 315 - 324.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Nattel
Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management?
Cardiovasc Res, May 1, 2002; 54(2): 347 - 360.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Shinagawa, H. Mitamura, S. Ogawa, and S. Nattel
Effects of inhibiting Na+/H+-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling
Cardiovasc Res, May 1, 2002; 54(2): 438 - 446.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Kurita, H. Mitamura, A. Shiroshita-Takeshita, A. Yamane, M. Ieda, O. Kinebuchi, T. Sato, S. Miyoshi, M. Hara, S. Takatsuki, et al.
Daily oral verapamil before but not after rapid atrial excitation prevents electrical remodeling
Cardiovasc Res, May 1, 2002; 54(2): 447 - 455.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Shinagawa, D. Li, T. K. Leung, and S. Nattel
Consequences of Atrial Tachycardia-Induced Remodeling Depend on the Preexisting Atrial Substrate
Circulation, January 15, 2002; 105(2): 251 - 257.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. B. Morton, M. J. Byrne, J. M. Power, J. Raman, and J. M. Kalman
Electrical Remodeling of the Atrium in an Anatomic Model of Atrial Flutter: Relationship Between Substrate and Triggers for Conversion to Atrial Fibrillation
Circulation, January 15, 2002; 105(2): 258 - 264.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Shi, A. Ducharme, D. Li, R. Gaspo, S. Nattel, and J.-C. Tardif
Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation
Cardiovasc Res, November 1, 2001; 52(2): 217 - 225.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S.P Fynn, D.M Todd, W.J.C Hobbs, K.L Armstrong, and C.J Garratt
Role of dispersion of atrial refractoriness in the recurrence of clinical atrial fibrillation. A manifestation of atrial electrical remodelling in humans?
Eur. Heart J., October 1, 2001; 22(19): 1822 - 1834.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
V. L.J.L. Thijssen, J. Ausma, and M. Borgers
Structural remodelling during chronic atrial fibrillation: act of programmed cell survival
Cardiovasc Res, October 1, 2001; 52(1): 14 - 24.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. A. Carnes, M. K. Chung, T. Nakayama, H. Nakayama, R. S. Baliga, S. Piao, A. Kanderian, S. Pavia, R. L. Hamlin, P. M. McCarthy, et al.
Ascorbate Attenuates Atrial Pacing-Induced Peroxynitrite Formation and Electrical Remodeling and Decreases the Incidence of Postoperative Atrial Fibrillation
Circ. Res., September 14, 2001; 89 (6): e32 - e38.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
E. BERTAGLIA, D. D'ESTE, A. ZANOCCO, F. ZERBO, and P. PASCOTTO
Effects of pretreatment with verapamil on early recurrences after electrical cardioversion of persistent atrial fibrillation: a randomised study
Heart, May 1, 2001; 85(5): 578 - 580.
[Full Text]


Home page
CirculationHome page
M. Vitadello, J. Ausma, M. Borgers, A. Gambino, D. C. Casarotto, and L. Gorza
Increased Myocardial GRP94 Amounts During Sustained Atrial Fibrillation : A Protective Response?
Circulation, May 1, 2001; 103(17): 2201 - 2206.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. H. Falk
Atrial Fibrillation
N. Engl. J. Med., April 5, 2001; 344(14): 1067 - 1078.
[Full Text] [PDF]


Home page
Eur Heart JHome page
C Pandozi and M Santini
Update on atrial remodelling owing to rate. Does atrial fibrillation always 'beget' atrial fibrillation?
Eur. Heart J., April 1, 2001; 22(7): 541 - 553.
[PDF]


Home page
J Am Coll CardiolHome page
H. Ramanna, A. Elvan, F. H. M. Wittkampf, J. M. T. de Bakker, R. N. W. Hauer, and E. O. Robles de Medina
Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation
J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1403 - 1407.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Benardeau, S. Fareh, and S. Nattel
Effects of verapamil on atrial fibrillation and its electrophysiological determinants in dogs
Cardiovasc Res, April 1, 2001; 50(1): 85 - 96.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
N. R Grubb and S. Furniss
Science, medicine, and the future: Radiofrequency ablation for atrial fibrillation
BMJ, March 31, 2001; 322(7289): 777 - 780.
[Full Text]


Home page
J Am Coll CardiolHome page
J.-L. Lin, L.-P. Lai, Y.-Z. Tseng, W.-P. Lien, and S. K. S. Huang
Global distribution of atrial ectopic foci triggering recurrence of atrial tachyarrhythmia after electrical cardioversion of long-standing atrial fibrillation: a bi-atrial basket mapping study
J. Am. Coll. Cardiol., March 1, 2001; 37(3): 904 - 910.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. J. J. M. Brundel, I. C. Van Gelder, R. H. Henning, A. E. Tuinenburg, M. Wietses, J. G. Grandjean, A. A. M. Wilde, W. H. Van Gilst, and H. J. G. M. Crijns
Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels
J. Am. Coll. Cardiol., March 1, 2001; 37(3): 926 - 932.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Sun, D. Chartier, N. Leblanc, and S. Nattel
Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes
Cardiovasc Res, March 1, 2001; 49(4): 751 - 761.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Fareh, A. Benardeau, and S. Nattel
Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs
Cardiovasc Res, March 1, 2001; 49(4): 762 - 770.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. J. J. M. Brundel, I. C. Van Gelder, R. H. Henning, R. G. Tieleman, A. E. Tuinenburg, M. Wietses, J. G. Grandjean, W. H. Van Gilst, and H. J. G. M. Crijns
Ion Channel Remodeling Is Related to Intraoperative Atrial Effective Refractory Periods in Patients With Paroxysmal and Persistent Atrial Fibrillation
Circulation, February 6, 2001; 103(5): 684 - 690.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. T. Altemose, D. P. Zipes, J. Weksler, J. M. Miller, and J. E. Olgin
Inhibition of the Na+/H+ Exchanger Delays the Development of Rapid Pacing-Induced Atrial Contractile Dysfunction
Circulation, February 6, 2001; 103(5): 762 - 768.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. J. Meurling, J. E. P. Waktare, F. Holmqvist, A. Hedman, A. J. Camm, S. B. Olsson, and M. Malik
Diurnal variations of the dominant cycle length of chronic atrial fibrillation
Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H401 - H406.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Pandozi, L. Bianconi, L. Calo, A. Castro, F. Lamberti, M. C. Scianaro, G. Gentilucci, and M. Santini
Postcardioversion atrial electrophysiologic changes induced by oral verapamil in patients with persistent atrial fibrillation
J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2234 - 2241.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Sticherling, H. Oral, J. Horrocks, S. P. Chough, R. L. Baker, M. H. Kim, K. Wasmer, F. Pelosi, B. P. Knight, G. F. Michaud, et al.
Effects of Digoxin on Acute, Atrial Fibrillation-Induced Changes in Atrial Refractoriness
Circulation, November 14, 2000; 102(20): 2503 - 2508.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. S. Friedman, M. Win, A. Hussain, and A. Sinha
Effects of Cardiac Glycosides on Atrial Contractile Dysfunction After Short-term Atrial Fibrillation
Chest, October 1, 2000; 118(4): 1116 - 1126.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. J. Ramirez, S. Nattel, and M. Courtemanche
Mathematical analysis of canine atrial action potentials: rate, regional factors, and electrical remodeling
Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1767 - H1785.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. H. Everett IV, H. Li, J. M. Mangrum, I. D. McRury, M. A. Mitchell, J. A. Redick, and D. E. Haines
Electrical, Morphological, and Ultrastructural Remodeling and Reverse Remodeling in a Canine Model of Chronic Atrial Fibrillation
Circulation, September 19, 2000; 102(12): 1454 - 1460.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Nattel and D. Li
Ionic Remodeling in the Heart : Pathophysiological Significance and New Therapeutic Opportunities for Atrial Fibrillation
Circ. Res., September 15, 2000; 87(6): 440 - 447.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. J. Sih, D. P. Zipes, E. J. Berbari, D. E. Adams, and J. E. Olgin
Differences in organization between acute and chronic atrial fibrillation in dogs
J. Am. Coll. Cardiol., September 1, 2000; 36(3): 924 - 931.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
C.J. Garratt and S.P. Fynn
Atrial electrical remodelling and atrial fibrillation
QJM, September 1, 2000; 93(9): 563 - 565.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. G. Manios, E. M. Kanoupakis, G. I. Chlouverakis, M. D. Kaleboubas, H. E. Mavrakis, and P. E. Vardas
Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation: relation with recurrence
Cardiovasc Res, August 1, 2000; 47(2): 244 - 253.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Li, A. Benardeau, and S. Nattel
Contrasting Efficacy of Dofetilide in Differing Experimental Models of Atrial Fibrillation
Circulation, July 4, 2000; 102(1): 104 - 112.
[Abstract] [Full Text] [PDF]